Symptom dimensions and their association with outcome and treatment setting in long-term schizophrenia

Nordic Journal of Psychiatry

Volumn 56, Issue 5, 2002, Pages 319-327

  Salokangas, Raimo K R ^a,b   Honkonen, Teija ^c   Stengård, Eija ^d   Koivisto, Aanna Maija ^e  

^a UNIVERSITY OF TURKU   (Finland)

^b Turku Psychiatric Clinic   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^e UNIVERSITY OF TAMPERE   (Finland)

Author keywords

Factors analysis; Outcome; Schizophrenia; Symptom dimension; Treatment setting

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC AGENT; NEUROLEPTIC AGENT; TRANQUILIZER;

ADOLESCENT; ADULT; ANAMNESIS; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DISEASE ASSOCIATION; DISEASE DURATION; DISORIENTATION; DIVORCE; FEMALE; FINLAND; FOLLOW UP; HOSPITAL DISCHARGE; HOSTILITY; HUMAN; INTERVIEW; LIFE SATISFACTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; SCHIZOPHRENIA; SCORING SYSTEM; SEX DIFFERENCE; SINGLE PARENT; SOCIAL PSYCHOLOGY; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHRONIC DISEASE; COMMUNITY MENTAL HEALTH SERVICES; FACTOR ANALYSIS, STATISTICAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PATIENT DISCHARGE; PSYCHIATRIC STATUS RATING SCALES; SAMPLING STUDIES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME;

EID: 0036031609     PISSN: 08039488     EISSN: None     Source Type: Journal    
DOI: 10.1080/080394802760322079     Document Type: Article

References (58)

1. Kraepelin E. Psychiatrie. Ein Lehrbuch für Studierende und Aerzte. Sechste, vollständig umgearbaitete Auflage. Leibzig: Johan Ambrosius Barth; 1899.
2. Bleuler E. Dementia Praecox oder die Gruppe der Schizophrenien. (Handbuch der Psychiatrie, herausgegeben von Prof. Dr. G. Aschaffenburg, Spez. Teil IV:1). Leipzig und Wien: Deuticke; 1911.
3. Langfeldt G. The schizophreniform states. Köbenhavn: Munksgaard; 1939.
4. Garmezy N, Rodnick EH. Premorbid adjustment and performance in schizophrenia: Implications for interpreting heterogeneity in schizophrenia. J Nerv Ment Disord 1959;129:450-66.
5. Crow TJ. Molecular pathology of schizophrenia: more than one dimension pathology? BMJ 1980;143:66-8.
6. Crow TJ. The two syndrome concept: origins and current status. Schizophr Bull 1985;11:471-85.
7. Liddle PF. The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy. Br J Psychiatry 1987;151:145-51.
8. Arndt S, Allinger RJ, Andreasen NC. The distinction of positive and negative symptoms. The failure of a two-dimensional model. Br J Psychiatry 1991;158:317-22.
9. Peralta V, de-Leon J, Cuest MJ. Are there more than two syndromes in schizophrenia? A critique of the positive-negative dichotomy. Br J Psychiatry 1992;161:335-43.
10. Schroder J, Geider FJ, Binkert M, Reitz C, Jauss M, Sauer H. Subsyndromes in chronic schizophrenia: do their psychopathological characteristics correspond to cerebral alterations? Psychiatr Res 1992;42:209-20.
11. Keefe RS, Harvey PD, Lenzenweger MF, Davidson M, Apter SH, Schmeidler J, et al. Empirical assessment of factorial structure of clinical symptoms in schizophrenia: negative symptoms. Psychiatry Res 1992;44:153-65.
12. Andreasen NC, Arndt S, Allinger R, Miller D, Flaum M. Symptoms of schizophrenia. Methods, meanings and mechanism. Arch Gen Psychiatry 1995;52:341-51.
13. Kay SR, Sevy S. Pyramidal model of schizophrenia. Schizophr Bull 1990;16:537-45.
14. Lepine JP. Dimensions positives et négatives dans les schizophrénies. Les Chahiers de Prisme 1991;1:23-9.
15. Lindström E, Von Knorring L. Princible component analysis of the Swedish version of the Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Nord J Psychiatry 1993;47:257-63.
16. Lindenmayer JP, Bernstein-Hyman R, Crochowski S. Five factor model of schizophrenia: initial validation. J Nerv Ment Disord 1994;182:631-8.
17. Mass R, Schoemig T, Hitschfeld K, Wall E, Haasen C. Psychopathological syndromes of schizophrenia: evaluation of the dimensional structure of the positive and negative syndrome scale. Schizophr Bull 2000;26:167-77.
18. Salokangas RKR. Structure of schizophrenic symptomatology and its changes over time: prospective factor-analytic study. Acta Psychiatr Scand 1997;95:32-9.
19. Salokangas RKR. Symptoms and psychosocial situation in schizophrenia. A prospective follow-up study. Nord J Psychiatry 1999;53:285-92.
20. Lääkintöhallitus. Tautiluokitus 1987. (Classification of diseases 1987.) Helsinki: Valtion painatuskeskus; 1986.
21. Endicott J, Spitzer RL, Fleis JL, Cohen J. The Global Assessment Scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976;33:766-71.
22. Strauss J, Carpenter W. The prediction of outcome in schizophrenia: I. Characteristics of outcome. Arch Gen Psychiatry 1972;27:739-46.
23. Creer C, Stuart E, Wykes T. The role of relatives in long-term community care: experiences in a London borough. In: Wing JK, editor. Psychol Med Monogr Suppl 1982;2:29-39.
24. Kay SR, Opler LA, Fiszbein A. Positive and negative syndrome scale (PANSS) rating manual. New York: Bronx Psychiatric Center; 1986.
25. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-76.
26. Harman HH. Modern factor analysis. Chicago: University of Chicago Press; 1976.
27. Salokangas RKR, Saarinen S. Deinstitutionalisation and schizophrenia in Finland: discharged patients and their care. A follow-up study of schizophrenic patients discharged from Finnish mental hospitals in 1982, 1986 and 1990. Schizophr Bull 1998;24:457-67.
28. Honkonen T, Saarinen S, Salokangas RKR. Deinstitutionalization and schizophrenia in Finland II: Discharged patients and their psychosocial functioning. Schizophr Bull 1999;25:543-51.
29. Salokangas RKR, Honkonen T, Stengård E. Discharged schizophrenia patients in the community - implications for service development. A follow-up study of schizophrenia patients discharged from Finnish mental hospitals in 1982, 1986, 1990 and 1994. Psychiatria Fennica 2001;Suppl 2:111-22.
30. Andreasen NC, Olsen S. Negative v. positive schizophrenia: definition and validation. Arch Gen Psychiatry 1982;39:789-94.
31. Kibel DA, Laffont I, Liddle PF. The composition of negative syndrome of chronic schizophrenia. Br J Psychiatry 1993;162:744-50.
32. Dollfus S, Petit M. Principal-component analyses of the PANSS and SANS-SAPS in schizophrenia: their stability in an acute phase. Eur Psychiatry 1995;10:97-106.
33. Jablensky A. Schizophrenia: the epidemiological horizon. In: Hirsch SR, Weinberger DR, editors. Schizophrenia. Cambridge: Blackwell Science; 1995. p. 206-52.
34. Affleck JW, Burns J, Forrest AD. Long-term follow-up of schizophrenic patients in Edinburgh. Acta Psychiat Scand 1976;53:227-37.
35. Lo WH, Lo T. A ten-year follow-up study of Chinese schizophrenics in Hong Kong. Br J Psychiatry 1977;131:63-6.
36. Bland RC, Orn H. 14-year outcome in early schizophrenia. Acta Psychiat Scand 1978;58:327-38.
37. Salokangas RKR. Psychosocial prognosis in schizophrenia. Formation of the prognosis for schizophrenic patients: A multivariate analysis. Turku: Annales Universitatis Turkuensis ser D 9; 1978.
38. Salokangas RKR. Prognostic implications of the sex of schizophrenic patients. Br J Psychiatry 1983;142:145-51.
39. Salokangas RKR. Psychosocial outcome in schizophrenia and psychotherapeutic orientation. Acta Psychiatr Scand 1986;74:497-506.
40. Wattie BJS, Kedward HB. Gender differences in living conditions found among male and female schizophrenic patients on a follow-up study. Int J Soc Psychiatry 1985;31:205-16.
41. Alanen YO, Räkköläinen V, Laakso J, Rasimus R, Kaljonen A. Towards need-specific treatment of schizophrenic psychoses. Heidelberg: Springer-Verlag; 1986.
42. Seeman MV. Current outcome in schizophrenia: women vs. men. Acta Psychiat Scand 1986;73:609-17.
43. Shepherd M, Watt D, Falloon I, Smeeton N. The natural history of schizophrenia: a five year follow-up study of outcome and prediction in a representative sample of schizophrenics. Psychol Med Monogr Suppl 1989;15.
44. Angermeyer MC, Goldstein JM, Kuehn L. Gender differences in schizophrenia: rehospitalization and community survival. Psychol Med 1989;19:365-82.
45. Salokangas RKR, Stengård E. Gender and short-term outcome in schizophrenia. Schizophr Res 1990;3:333-45.
46. Räsänen S, Pakaslahti A, Syvälahti E, Jones PB, Isohanni M. Sex differences in schizophrenia: A review. Nord J Psychiatry 2000;54:37-45.
47. Danielsson K, Flyckt L, Edman G. Sex differences in schizophrenia as seen in the Rorschach test. Nord J Psychiatry 2001;55:137-42.
48. Kessler RC, Brown RL, Broman CL. Sex differences on psychiatric help-seeking: evidence from four large-scale surveys. J Health Soc Behav 1981;22:49-64.
49. Weissman MM, Klerman GL. Gender and depression. Trends Neurosci 1985;8:416-20.
50. Häfner H, Hambrecht M, Loffler W, Munk-Jörgensen P, Riecher-Rössler A. Is schizophrenia a disorder of all ages? A comparison of first episodes and early course across the life-cycle. Psychol Med 1998;28:351-65.
51. Wing JK, Brown GW. Institutionalization and schizophrenia. Cambridge: Cambridge University Press; 1970.
52. Taiminen T, Salokangas RKR, Saarijärvi S, Syvälahti E, Niemi H, Ahola V, Lehto H. Symptom dimensions, social network, and caregiver in chronic schizophrenia. Nord J Psychiatry 2000;54:121-5.
53. Salokangas RKR, Poutanen O. Risk factors for depression in primary care. Findings of the TADEP project. J Affect Disord 1998;48:171-80.
54. Vaillant GE. Prospective prediction of schizophrenic remission. Arch Gen Psychiatry 1964;11:509-18.
55. Ciompi L, Müller C. Lebensweg und Alter der Schizophrenen. Eine katamnestische Langzeitstudie his ins Senium. Berlin-Heidelberg: Springer-Verlag; 1976.
56. Gross G, Huber G. Classification and prognosis of schizophrenic disorders in light of the Bonn follow-up studies, Psychopathology 1986;19:50-9.
57. Lindström E, Von Knorring L, Ekselius L. Self-reported personality disorders in patients with schizophrenia and the relationship to symptoms, side effects, and social functioning. Nord J Psychiatry 2000;54:341-6.
58. Mojtabai R, Nicholson RA, Carpenter BN. Role of psychosocial treatments in management of schizophrenia: a meta-analytic review of controlled outcome studies. Schizophr Bull 1998;24:569-87.